Home>>Signaling Pathways>> Obesity, Appetite Control & Diabetes>> Diabetes>>9(10)-Nitrooleate

9(10)-Nitrooleate

(Synonyms: 9(10)-Nitrooleic Acid; OA-NO2; 9(10)-nitro-9-trans-Octadecenoic Acid) 目录号 : GC92043

9(10)-Nitrooleate是一种硝基烯内源性脂质信号分子9-硝基油酸酯的混合物。

9(10)-Nitrooleate Chemical Structure

Cas No.:1092676-99-7

规格 价格 库存 购买数量
100 µg
¥630.00
现货
500 µg
¥1,582.00
现货
1 mg
¥2,520.00
现货

电话:400-920-5774 Email: sales@glpbio.cn

Customer Reviews

Based on customer reviews.

Sample solution is provided at 25 µL, 10mM.

Description

9(10)-Nitrooleate is a mixture of the nitroalkene endogenous lipid signaling molecules 9-nitrooleate. 9(10)-Nitrooleate is formed by nitration of oleic acid by peroxynitrite, acidified nitrite, and myeloperoxidase in the presence of hydrogen peroxide (H2O2) and nitrite.1 It induces transactivation of peroxisome proliferator-activated receptor γ (PPARγ) or nuclear factor erythroid 2-related factor 2 (Nrf2) in reporter assays using MCF-7 cells when used at concentrations greater than or equal to 0.3 and greater than or equal to 3 ?M, respectively.2 9(10)-Nitrooleate also induces transactivation of PPARγ, PPARδ, or PPARα in reporter assays using CV-1 cells in a concentration-dependent manner.1 It induces adipogenesis in 3T3-L1 preadipocytes and glucose uptake in differentiated 3T3-L1 adipocytes when used at a concentration of 3 ?M. In vivo, 9(10)-nitrooleate (500 ?g/kg every six hours for 24 hours) decreases ischemia-induced increases in plasma levels of blood urea nitrogen, creatinine, and TNF-α and kidney levels of myeloperoxidase (Mpo) and IL-1β and reduces tubular necrosis and tubule dilation in a mouse model of renal ischemia-reperfusion injury.3

References:
[1]. Baker, P.R., Lin, Y., Schopfer, F.J., et al.Fatty acid transduction of nitric oxide signaling. Multiple nitrated unsaturated acid derivatives exist in human blood and urine serve as endogenous peroxisome proliferator-activated receptor ligandsJ. Biol. Chem.280(51)42464-42475(2005).
[2]. Bates, D.J.P., Smitherman, P.K., Townsend, A.L., et al.Nitroalkene fatty acids mediate activation of Nrf2/ARE-dependent and PPARγ-dependent transcription by distinct signaling pathways and with significantly different potenciesBiochemistry50(36)7765-7773(2011).
[3]. Liu, H., Jia, Z., Soodvilai, S., et al.Nitro-oleic acid protects the mouse kidney from ischemia and reperfusion injuryAm. J. Physiol. Renal. Physiol.295(4)F942-F949(2008).

化学性质

Cas No. 1092676-99-7 SDF
别名 9(10)-Nitrooleic Acid; OA-NO2; 9(10)-nitro-9-trans-Octadecenoic Acid
化学名 9-nitro-9E-octadecenoic acid, 10-nitro-9E-octadecenoate
Canonical SMILES CCCCCCCC/C=C([N+]([O-])=O)\CCCCCCCC(O)=O.CCCCCCCC/C([N+]([O-])=O)=C\CCCCCCCC(O)=O
分子式 C18H33NO4 ? C18H33NO4 分子量 654.9
溶解度 Ethanol: Slightly soluble: 0.1-1 mg/ml 储存条件 -20°C
General tips 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。
为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。
Shipping Condition 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。

溶解性数据

制备储备液
1 mg 5 mg 10 mg
1 mM 1.527 mL 7.6348 mL 15.2695 mL
5 mM 0.3054 mL 1.527 mL 3.0539 mL
10 mM 0.1527 mL 0.7635 mL 1.527 mL
  • 摩尔浓度计算器

  • 稀释计算器

  • 分子量计算器

质量
=
浓度
x
体积
x
分子量
 
 
 
*在配置溶液时,请务必参考产品标签上、MSDS / COA(可在Glpbio的产品页面获得)批次特异的分子量使用本工具。

计算

动物体内配方计算器 (澄清溶液)

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
给药剂量 mg/kg 动物平均体重 g 每只动物给药体积 ul 动物数量
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方)
% DMSO % % Tween 80 % saline
计算重置

产品文档

Quality Control & SDS

View current batch: